Mission
MPN Research Foundation is dedicated to funding and advancing original research for new treatments and cures for essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF), blood cancers collectively known as myeloproliferative neoplasms (MPNs). Founded in 1999, MPN Research Foundation operates at the intersection of patients, researchers, and the biotech industry, facilitating a collaborative approach to research that elevates the patient voice.
Basic Information
Tax-Exempt
Founded in
1999
EIN
36-4330967
Total Assets
$8.746 million
UN Sustainable Development Goals Supported
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.
Showing 3 of 4 goals
At a Glance
Join the Fight Against MPNs
Celebrate the discoveries funded by MPN Research Foundation to advance treatment options.
Check Out MPN Challenge Grants
MPN Challenge grants support innovative research projects focusing on critical areas in MPN research.
Explore Patient Stories
Real stories from patients and caregivers highlighting the journey of living with MPNs.
Impact Stats
$20.1M
Funding Amount
Total Funding
Total dollars invested in research for MPNs.
105
Number of Projects
Research Projects Funded
Projects funded to advance MPN research.
99
Number of Researchers
Researchers Supported
Number of researchers supported across the globe.
9
Number of Countries
Global Countries Involved
Countries where MPN research has been supported.
Our Programs
MPN Challenge
An open request for applications focusing on innovative research to advance the understanding and treatment of MPNs.
Learn MorePatient-Focused Drug Development
A program that emphasizes the patient voice in MPN research, ensuring treatment development aligns with patient needs.
Learn MoreMIP Score (Beta)
The MIP Score is in beta! We'd love any feedback you may have.
The MIP Score and it's methodology is purely used as a way to visualize how a nonprofits public financial data compares against others. It doesn't reflect the unique circumstances and impact that a nonprofit has.The MIP Score should never be used to say one charity is better than another.
Overall Score
64
50
/100
Program Expense Ratio
86.09%
18
/20
Program Revenue Growth
0.00%
2
/20
Leverage Ratio
0.2372
14
/20
Working Capital Ratio
1.82
14
/20
Fundraising Efficiency
0
2
/20
Latest Filing Data: Form 990
Fiscal Year:2022
Source:Source: Self-reported by organization
Financial Details
Revenue
| Category | Amount | Percentage |
|---|---|---|
| Contributions, Gifts, and Grants | 3.745M | 96.13% |
| Program Services | 0 | 0.00% |
| Investment Income | 150.7K | 3.87% |
| Sales of Non-Inventory Assets | 0 | 0.00% |
| Other Notable Sources | 0 | 0.00% |
| Total Revenue | 3.896M | 100.00% |
Related Nonprofits
Sierra Rayn Childrens Neuroblastoma Foundation Inc.
Med Research
Orthopedic ResearchAmerican Bone Health
Med Research
Orthopedic ResearchSetting Scoliosis Straight Foundation
Med Research
Orthopedic ResearchRare Trait Hope Fund
Med Research
Orthopedic ResearchInternational Neuromodulation Society
Med Research
Orthopedic Research